One of the leading
causes of disability in the elderly is the pain associated with knee
osteoarthritis (OA). Chronic pain from knee OA can decrease physical activity,
increasing the risk for chronic disease, decreased functional independence and
diminished quality of life. In spite of the increased prevalence of knee OA in
women, there has been limited investigation into the factors underlying the sex
disparity of knee OA. And urinary estradiol (E2) metabolites were shown to be
associated with the incidence of knee OA in perimenopausal women. In this
paper, the authors aimed to determine the associations between urinary
estradiol (E2) metabolite concentration and medial knee loading with
radiographic disease severity in middle aged women with initial stage knee
osteoarthritis (OA).
Women presenting
with knee pain were recruited into a cross-sectional correlation study (KOA, n
= 9, age = 52 ± 4 yrs). Self-report menstrual history, the Modified Baecke
Questionnaire and the Knee Injury and Osteoarthritis Outcome Score (KOOS)
subjective data were collected. A fasting blood sample (follicle stimulating
hormone (FSH) and Tumor Necrosis Factor-α (TNF-α)), and
urine catch (16α-hydroxyestrone and 2-hydroxyestrone) were collected.
Gait analysis using an 8-camera motion analysis system assessed internal knee
varus moment and foot progression angle. Pearson Product moments tested for
associations between urinary 16α-hydroxyestrone and 2-hydroxyestrone,
TNF-α, medial knee loading, and radiographic disease severity
(Kellgren/Lawrence (K/L) radiographic score).
Significant
correlations were found within the hormonal biomarkers (r = 0.94, p <
0.001) and within the biomechanical markers (r = 0.76,p < 0.02),
but not between hormonal and biomechanical variables (r = 0.39, p =
0.31). No correlations were found for radiographic disease severity or TNF-α.
In summary, the
results of this study did not support the hypothesized association between
urinary E2 metabolite concentration and medial knee loading for
women with initial stage knee OA in the menopause transition. This finding may
be due to the large variability of the E2 metabolites seen in the
menopause transition, as well as, the limited structural changes of initial
staged knee OA.
Article by David
S. Mandeville, et al, from USA.
Full access: http://mrw.so/2pwuCb
Image by Iffie Okoronkwo, M.D., from
Flickr-cc.

评论
发表评论